Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (FY)Oct 31, 2025 | (Q1)Jan 31, 2025 | (FY)Oct 31, 2024 | (Q2)Apr 30, 2024 | (Q1)Jan 31, 2024 | (FY)Oct 31, 2023 | (Q4)Oct 31, 2023 | (Q3)Jul 31, 2023 | (Q2)Apr 30, 2023 | (Q1)Jan 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | 8.41%124.9B | 13.21%33.42B | 5.12%115.21B | 4.64%30.17B | 9.59%29.52B | 6.21%109.59B | 7.13%27.37B | 8.43%26.45B | 11.08%28.83B | -1.27%26.94B |
| Cost of revenue | 8.96%105.25B | 14.61%28.55B | 4.94%96.59B | 2.38%24.76B | 9.01%24.91B | 6.30%92.04B | 4.14%22.94B | 8.63%22.06B | 11.85%24.18B | 1.02%22.85B |
| Gross profit | 5.54%19.65B | 5.66%4.87B | 6.07%18.62B | 16.44%5.41B | 12.80%4.61B | 5.71%17.55B | 25.80%4.43B | 7.44%4.4B | 7.22%4.65B | -12.37%4.09B |
| Operating expense | 6.77%14.71B | 8.98%3.72B | 1.89%13.77B | 8.68%3.51B | 0.34%3.41B | 5.15%13.52B | 7.05%3.59B | 2.98%3.3B | 4.25%3.23B | 6.22%3.4B |
| Staff costs | 3.57%4.34B | ---- | -2.89%4.19B | ---- | ---- | 5.13%4.32B | ---- | ---- | ---- | ---- |
| Selling and administrative expenses | 0.94%5.19B | ---- | 3.39%5.14B | ---- | ---- | 5.64%4.98B | ---- | ---- | ---- | ---- |
| -Selling and marketing expense | 1.34%1.3B | ---- | 0.48%1.28B | ---- | ---- | 13.20%1.28B | ---- | ---- | ---- | ---- |
| -General and administrative expense | 0.80%3.89B | ---- | 4.40%3.86B | ---- | ---- | 3.26%3.7B | ---- | ---- | ---- | ---- |
| Rent and land expenses | -1.79%494.34M | ---- | -3.45%503.36M | ---- | ---- | -2.65%521.33M | ---- | ---- | ---- | ---- |
| Other operating expenses | 18.92%4.68B | ---- | 6.17%3.93B | ---- | ---- | 5.71%3.71B | ---- | ---- | ---- | ---- |
| Operating profit | 2.02%4.94B | -3.80%1.15B | 20.08%4.84B | 34.19%1.9B | 74.77%1.19B | 7.62%4.03B | 399.98%839.27M | 23.51%1.1B | 14.68%1.41B | -53.15%683.7M |
| Net non-operating interest income (expenses) | -78.08%-227.28M | -55.57%-40.49M | -16.80%-127.63M | 10.26%-26.94M | 4.33%-26.03M | -2.49%-109.27M | -8.21%-27.46M | 13.63%-24.58M | -14.41%-30.02M | -2.53%-27.2M |
| Non-operating interest income | -25.73%11.59M | -61.35%2.11M | -21.39%15.6M | 139.97%5.66M | 64.52%5.45M | 50.51%19.85M | 83.04%7.02M | 90.96%7.16M | -22.15%2.36M | 28.69%3.32M |
| Non-operating interest expense | 66.77%238.87M | 35.31%42.6M | 10.93%143.23M | 0.68%32.6M | 3.15%31.48M | 7.78%129.12M | 18.03%34.48M | -1.45%31.74M | 10.63%32.38M | 4.84%30.52M |
| Net investment income | 23.50%130.77M | 782.37%93.27M | 16.27%105.89M | 234.07%73.23M | 117.14%10.57M | -69.20%91.07M | -26.67%27.02M | -21.94%103.8M | -75.71%21.92M | -273.30%-61.68M |
| Gain(Loss) on financial instruments designated as cash flow hedges | ||||||||||
| Gain(Loss) on derecognition of available-for-sale financial assets | -2.95M | |||||||||
| Income from associates and other participating interests | 8.03%26.58M | 25.46%11.21M | 14.44%24.6M | 147.90%2.42M | -15.61%8.93M | -19.16%21.5M | -88.25%267K | -11.62%9.67M | -17.02%975K | -13.24%10.59M |
| Special income (charges) | -4,300.06%-323.53M | -13,580.82%-289.62M | 137.16%7.7M | -1,473.20%-4.77M | -273.37%-2.12M | -705.73%-20.73M | -173.70%-12.46M | 1.64%-8.05M | 109.91%347K | 68.64%-567K |
| Less:Other special charges | 4,300.06%323.53M | 13,580.82%289.62M | -137.16%-7.7M | 1,473.20%4.77M | 273.37%2.12M | 705.73%20.73M | 173.70%12.46M | -1.64%8.05M | -109.91%-347K | -68.64%567K |
| Other non-operating income (expenses) | -125.00%-25.78M | 33.04%28.81M | 3.72%103.12M | -56.95%20.7M | 4.30%21.65M | -23.74%99.42M | -76.46%16.08M | -35.67%14.5M | 307.73%48.08M | -25.16%20.76M |
| Income before tax | -8.83%4.52B | -21.13%952.71M | 20.45%4.96B | 34.82%1.96B | 93.08%1.21B | 0.44%4.12B | 215.85%842.7M | 17.13%1.19B | 11.40%1.46B | -58.48%625.6M |
| Income tax | -18.68%1.39B | -25.59%466.14M | 35.05%1.71B | 30.67%555.45M | 123.07%626.49M | 1.29%1.27B | 174.51%229.47M | 29.67%331.26M | -0.15%425.08M | -42.19%280.85M |
| Net income | -3.64%3.13B | -16.32%486.57M | 13.96%3.25B | 36.54%1.41B | 68.65%581.44M | 0.07%2.85B | 234.71%613.23M | 12.93%861.77M | 16.98%1.03B | -66.23%344.75M |
| Net income continuous operations | -3.64%3.13B | -16.32%486.57M | 13.96%3.25B | 36.54%1.41B | 68.65%581.44M | 0.07%2.85B | 234.71%613.23M | 12.93%861.77M | 16.98%1.03B | -66.23%344.75M |
| Noncontrolling interests | 20.50%93.78M | 71.87%8.95M | 90.82%77.83M | 74.09%33.75M | -21.17%5.21M | -31.57%40.79M | -1,578.95%-1.41M | -25.54%16.2M | -29.27%19.38M | -36.17%6.61M |
| Net income attributable to the company | -4.24%3.04B | -17.11%477.62M | 12.85%3.17B | 35.82%1.37B | 70.41%576.23M | 0.75%2.81B | 235.65%614.63M | 14.06%845.57M | 18.46%1.01B | -66.54%338.14M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Net income attributable to common stockholders | -4.24%3.04B | -17.11%477.62M | 12.85%3.17B | 35.82%1.37B | 70.41%576.23M | 0.75%2.81B | 235.65%614.63M | 14.06%845.57M | 18.46%1.01B | -66.54%338.14M |
| Gross dividend payment | ||||||||||
| Basic earnings per share | -3.65%181.31 | -17.16%28.34 | 12.81%188.18 | 35.78%81.51 | 70.37%34.21 | 0.71%166.81 | 235.39%36.49 | 14.04%50.21 | 18.43%60.03 | -66.55%20.08 |
| Diluted earnings per share | -3.65%181.31 | -17.16%28.34 | 12.81%188.18 | 35.76%81.4942 | 70.37%34.21 | 0.71%166.81 | 235.51%36.49 | 14.04%50.21 | 18.43%60.03 | -66.55%20.08 |
| Dividend per share | 25.00%60 | 0 | 0.00%48 | 0.00%24 | 0 | 0.00%48 | 0.00%24 | 0 | 0.00%24 | 0 |
| Currency Unit | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY | JPY |
| Accounting Standards | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP | NonUS-GAAP |